Skip to content
10-Q

Quarterly Report

EMERGENT BIOSOLUTIONS INC. EBS

0001367644-25-000181

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 30, 2025 53.35M sh
Shares Diluted Q2 2025 · Jun 30, 2025 54.2M sh
Shares Diluted Q2 2025 · Jun 30, 2025 56.7M sh
Shares Diluted Q2 2025 · Jun 30, 2024 52.6M sh
Shares Diluted Q2 2025 · Jun 30, 2024 52.4M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $6.9M
Stock Repurchased Q2 2025 · Jun 30, 2024 $0
Capex Q2 2025 · Jun 30, 2025 $6.5M
Capex Q2 2025 · Jun 30, 2024 $15.4M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $95.2M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$15.1M
Long Term Debt Q2 2025 · Jun 30, 2025 $667.8M
Long Term Debt Q2 2025 · Dec 31, 2024 $663.7M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $267.3M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $99.5M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $69.7M
Stockholders Equity Q2 2025 · Jun 30, 2025 $536.2M
Stockholders Equity Q2 2025 · Mar 31, 2025 $552.7M
Stockholders Equity Q2 2025 · Dec 31, 2024 $482.8M
Stockholders Equity Q2 2025 · Jun 30, 2024 $386.3M
Stockholders Equity Q2 2025 · Mar 31, 2024 $663.9M
Stockholders Equity Q2 2025 · Dec 31, 2023 $649.3M
Current Liabilities Q2 2025 · Jun 30, 2025 $127.1M
Current Liabilities Q2 2025 · Dec 31, 2024 $162.4M
Total Liabilities Q2 2025 · Jun 30, 2025 $880.9M
Total Liabilities Q2 2025 · Dec 31, 2024 $906.9M
Current Assets Q2 2025 · Jun 30, 2025 $719.5M
Current Assets Q2 2025 · Dec 31, 2024 $598.7M
Total Assets Q2 2025 · Jun 30, 2025 $1.42B
Total Assets Q2 2025 · Dec 31, 2024 $1.39B
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.22
Eps Diluted Q2 2025 · Jun 30, 2025 $0.99
Eps Diluted Q2 2025 · Jun 30, 2024 −$5.38
Eps Diluted Q2 2025 · Jun 30, 2024 −$5.23
Eps Basic Q2 2025 · Jun 30, 2025 −$0.22
Eps Basic Q2 2025 · Jun 30, 2025 $1.03
Eps Basic Q2 2025 · Jun 30, 2024 −$5.38
Eps Basic Q2 2025 · Jun 30, 2024 −$5.23
Sga Expense Q2 2025 · Jun 30, 2025 $43.7M
Sga Expense Q2 2025 · Jun 30, 2025 $96.1M
Sga Expense Q2 2025 · Jun 30, 2024 $85.9M
Sga Expense Q2 2025 · Jun 30, 2024 $170.6M
Rd Expense Q2 2025 · Jun 30, 2025 $12.5M
Rd Expense Q2 2025 · Jun 30, 2025 $27.6M
Rd Expense Q2 2025 · Jun 30, 2024 $32.7M
Rd Expense Q2 2025 · Jun 30, 2024 $47.8M
Net Income Q2 2025 · Jun 30, 2025 −$12M
Net Income Q2 2025 · Jun 30, 2025 $56M
Net Income Q2 2025 · Mar 31, 2025 $68M
Net Income Q2 2025 · Jun 30, 2024 −$283.1M
Net Income Q2 2025 · Jun 30, 2024 −$274.1M
Net Income Q2 2025 · Mar 31, 2024 $9M
Operating Income Q2 2025 · Jun 30, 2025 $1.6M
Operating Income Q2 2025 · Jun 30, 2025 $51.5M
Operating Income Q2 2025 · Jun 30, 2024 −$203.5M
Operating Income Q2 2025 · Jun 30, 2024 −$163.7M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $66.9M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $155.4M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $296.1M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $440.7M
Revenue Q2 2025 · Jun 30, 2025 $140.9M
Revenue Q2 2025 · Jun 30, 2025 $363.1M
Revenue Q2 2025 · Jun 30, 2024 $254.7M
Revenue Q2 2025 · Jun 30, 2024 $555.1M